ARTICLE | Company News
Algeta, Lumiphore deal
November 1, 2010 7:00 AM UTC
Algeta received an exclusive option for exclusive rights to use Lumiphore's Lumi4 isophthalamide chelation technology to develop targeted radiopharmaceutical therapeutics for cancer and companion diag...